Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.
Jim Cramer says Kroger is 'terrific,' but Dunkin' is 'just fine.'
We're beginning to see the grimmer side of the 'Trump Rally,' says Jim Cramer.
Here are Wednesday's top research calls, including upgrades for Nucor and Square, and downgrades for Tableau and Pfizer.
The physician-run company is more likely to buy than be bought.